Vazyme(SH:688105) Zhong Guo Jing Ji Wang·2025-09-03 03:14Core Viewpoint - The major shareholder of NuoVance, Guoshou Chengda, plans to reduce its stake in the company due to personal funding needs, with a total reduction of up to 11,932,036 shares, representing no more than 3% of the total share capital [1][2]. Summary by Relevant Sections Shareholder Reduction Plan - Guoshou Chengda intends to reduce its holdings through block trading and centralized bidding, with a maximum of 3,977,345 shares through centralized bidding and 7,954,691 shares through block trading [2]. - The reduction period is set from September 24, 2025, to December 23, 2025 [2]. Shareholding Details - Guoshou Chengda currently holds 30,957,960 shares, accounting for 7.78% of NuoVance's total share capital [1][2]. - The shares to be reduced were acquired prior to the company's initial public offering (IPO) and were released from restrictions on November 15, 2022 [1]. IPO Information - NuoVance was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on November 15, 2021, with an issuance of 40.01 million shares at a price of 55.00 yuan per share [2]. - The total funds raised from the IPO amounted to 2.201 billion yuan, with a net amount of 2.109 billion yuan after deducting issuance costs [2]. - The final net fundraising exceeded the original plan by 907 million yuan, with the funds intended for headquarters and new R&D base projects, marketing network expansion, and working capital [2].